1. Home
  2. CADL vs PMO Comparison

CADL vs PMO Comparison

Compare CADL & PMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$11.33

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

PMO

Putnam Municipal Opportunities Trust

N/A

Current Price

$9.77

Market Cap

278.8M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
CADL
PMO
Founded
1999
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
278.8M
IPO Year
2021
1994

Fundamental Metrics

Financial Performance
Metric
CADL
PMO
Price
$11.33
$9.77
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$19.00
N/A
AVG Volume (30 Days)
1.2M
53.4K
Earning Date
05-14-2026
01-01-0001
Dividend Yield
N/A
4.10%
EPS Growth
58.62
N/A
EPS
N/A
N/A
Revenue
$125,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$25.02
Revenue Growth
N/A
N/A
52 Week Low
$4.35
$9.88
52 Week High
$14.00
$10.87

Technical Indicators

Market Signals
Indicator
CADL
PMO
Relative Strength Index (RSI) 42.84 19.53
Support Level $4.91 N/A
Resistance Level $11.36 $10.80
Average True Range (ATR) 0.69 0.10
MACD -0.26 -0.04
Stochastic Oscillator 5.54 1.56

Price Performance

Historical Comparison
CADL
PMO

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About PMO Putnam Municipal Opportunities Trust

Putnam Municipal Opportunities Trust is a non-diversified closed-end management investment company. It seeks to provide as high a level of current income free from federal income tax as Putnam Management believes is consistent with the preservation of capital. The fund invests in healthcare, utilities, transportation, leases, local, Housing, education, and Others.

Share on Social Networks: